ArticlePreventive medicine reports2026
Social determinants of stroke prevalence in the United States adults: Analysis of 42 states using behavioral risk factor surveillance system 2022 data.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Social determinants of health (SDOH) significantly influence stroke outcomes and impose substantial cost burdens on the US health system. This study examined the composite effect of SDOH on prevalent stroke beyond clinical factors, highlighting comorbidity and structural inequalities using a statewide representative survey. Methods: 232,155 adults across 42 U.S. states were analyzed using the 2022 Behavioral Risk Factor Surveillance System (BRFSS). A composite index of SDOH was developed based on adverse exposures. A series of logistic regression models adjusting for sociodemographic, behavioral, and health-related covariates estimated the association between the SDOH index and prevalent stroke. An additional model examined the comorbid conditions. Weighted estimates were used, with 95 % CI and a significance level of Results: The age-adjusted prevalence ranged from 3.44 % among those with one adverse SDOH to 9.03 % among those with four or more exposures. Four or more SDOH were associated with prevalent stroke (OR: 1.44, 95 % CI: 1.23, 1.68) in the fully adjusted logistic regression model. Multimorbidity was associated with 3.52 times higher odds of prevalent stroke (95 % CI: 3.11, 3.98). Conclusion: Adverse exposures to ≥4 SDOH significantly predicted prevalent stroke among U.S. adults. Addressing causal pathways involving multimorbidity in the SDOH-stroke relationship is critical for targeted interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.